Free Trial

C4 Therapeutics (CCCC) Institutional Ownership

C4 Therapeutics logo
$3.95 +0.10 (+2.60%)
(As of 12/20/2024 05:31 PM ET)

Institutional Ownership Changes (13F Filings) for C4 Therapeutics (NASDAQ:CCCC)

Current
Institutional Ownership
Percentage
78.81%
Number of
Institutional Buyers
(last 12 months)
43
Total
Institutional Inflows
(last 12 months)
$73.74M
Number of
Institutional Sellers
(last 12 months)
19
Total
Institutional Outflows
(last 12 months)
$40.37M
Get CCCC Insider Trade Alerts

Want to know when executives and insiders are buying or selling C4 Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

CCCC Institutional Buying and Selling by Quarter

C4 Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/27/2024 Franklin Resources Inc.34,383$202K0.0%N/A0.049%
11/19/2024 Barclays PLC243,457$1.39M0.0%+38.4%0.345%
11/18/2024 Arete Wealth Advisors LLC73,350$418K0.0%-34.1%0.104%
11/16/2024 Geode Capital Management LLC1,369,676$7.81M0.0%+0.5%1.940%
11/15/2024 Vestcor Inc29,500$168K0.0%N/A0.042%
11/15/2024 M&T Bank Corp113,907$649K0.0%+19.3%0.161%
11/15/2024 Barclays PLC243,457$1.39M0.0%+38.4%0.345%
11/15/2024 XTX Topco Ltd84,951$484K0.0%N/A0.120%
11/15/2024 Wellington Management Group LLP286,041$1.63M0.0%+24.7%0.405%
11/15/2024 Wexford Capital LP55,231$315K0.1%N/A0.078%
11/15/2024 State Street Corp2,806,913$16.00M0.0%-6.3%3.976%
11/15/2024 Point72 DIFC Ltd8,873$51K0.0%N/A0.013%
11/15/2024 Point72 Asset Management L.P.1,201,848$6.85M0.0%+331.4%1.703%
11/15/2024 ArrowMark Colorado Holdings LLC1,319,484$7.52M0.1%+6.0%1.869%
11/14/2024 Wasatch Advisors LP5,677,368$32.36M0.2%+17.1%8.043%
11/14/2024 MetLife Investment Management LLC35,455$202K0.0%+129.1%0.050%
11/13/2024 Cynosure Group LLC10,007$57K0.0%N/A0.014%
11/13/2024 FMR LLC185,941$1.06M0.0%+687.0%0.263%
11/13/2024 The Manufacturers Life Insurance Company41,664$237K0.0%+81.8%0.059%
11/12/2024 Charles Schwab Investment Management Inc.482,929$2.75M0.0%-1.2%0.684%
11/9/2024 Intech Investment Management LLC27,126$155K0.0%N/A0.038%
11/7/2024 LMR Partners LLP51,000$291K0.0%N/A0.072%
11/6/2024 Cornercap Investment Counsel Inc.11,791$67K0.0%-56.5%0.017%
11/5/2024 Aigen Investment Management LP14,344$82K0.0%N/A0.020%
11/5/2024 GSA Capital Partners LLP15,446$88K0.0%-33.6%0.022%
10/23/2024 Hennion & Walsh Asset Management Inc.192,364$1.10M0.1%+34.7%0.280%
10/3/2024 SG Americas Securities LLC24,941$142K0.0%N/A0.036%
9/16/2024 Cubist Systematic Strategies LLC560,959$2.59M0.0%-26.7%0.815%
8/19/2024 Point72 Asset Management L.P.278,580$1.29M0.0%-69.3%0.405%
8/19/2024 B. Riley Wealth Advisors Inc.11,000$51K0.0%N/A0.016%
8/15/2024Susquehanna Fundamental Investments LLC129,801$600K0.0%+152.7%0.189%
8/15/2024 Lynx1 Capital Management LP6,880,527$31.79M11.5%+89.3%10.000%
8/15/2024 The Manufacturers Life Insurance Company22,918$106K0.0%-68.3%0.033%
8/14/2024 Squarepoint Ops LLC57,117$264K0.0%-58.3%0.083%
8/14/2024 Cubist Systematic Strategies LLC560,959$2.59M0.0%-26.7%0.815%
8/14/2024 Profund Advisors LLC34,149$158K0.0%-73.0%0.050%
8/12/2024 Marathon Trading Investment Management LLC14,400$67K0.0%-77.5%0.021%
8/12/2024 E Fund Management Co. Ltd.11,280$52K0.0%-71.4%0.016%
8/9/2024 Renaissance Technologies LLC235,200$1.09M0.0%-42.0%0.342%
8/9/2024 Dimensional Fund Advisors LP619,112$2.86M0.0%-2.1%0.900%
Nvidia’s Bold Move: Tackling Tech’s $1 Trillion Crisis (Ad)

Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …

Find out details on these three critical Nvidia partners immediately.
8/8/2024 Cornercap Investment Counsel Inc.27,136$125K0.0%N/A0.039%
8/8/2024 American Century Companies Inc.110,075$509K0.0%+23.9%0.160%
8/7/2024 Headlands Technologies LLC9,652$45K0.0%N/A0.014%
8/6/2024 Acadian Asset Management LLC113,436$524K0.0%+415.8%0.165%
8/1/2024 Rhumbline Advisers90,621$419K0.0%+4,959.8%0.132%
8/1/2024 Hussman Strategic Advisors Inc.42,000$194K0.1%N/A0.061%
7/26/2024 Bank of New York Mellon Corp190,761$881K0.0%N/A0.277%
7/20/2024 Hennion & Walsh Asset Management Inc.142,832$660K0.0%N/A0.208%
5/30/2024 Lynx1 Capital Management LP3,634,662$29.70M7.6%+16.0%5.282%
5/24/2024 Farallon Capital Management LLC28,000$229K0.0%N/A0.041%
5/16/2024 Bain Capital Life Sciences Investors LLC1,142,210$9.33M0.7%-30.4%1.660%
5/16/2024 Caxton Associates LP21,002$172K0.0%N/A0.031%
5/15/2024 Bellevue Group AG57,600$471K0.0%-7.1%0.084%
5/15/2024 Price T Rowe Associates Inc. MD2,115,477$17.28M0.0%-17.3%3.074%
5/14/2024 EntryPoint Capital LLC28,516$233K0.2%N/A0.041%
5/10/2024 Acadian Asset Management LLC21,993$179K0.0%-87.0%0.032%
5/10/2024 Vanguard Group Inc.2,920,028$23.86M0.0%+46.0%4.244%
5/8/2024 Entropy Technologies LP15,391$126K0.0%N/A0.022%
5/7/2024Susquehanna Fundamental Investments LLC51,365$420K0.0%N/A0.075%
5/7/2024 SG Americas Securities LLC22,368$183K0.0%N/A0.033%
5/1/2024 Mirae Asset Global Investments Co. Ltd.41,445$339K0.0%N/A0.060%
4/18/2024 Wasatch Advisors LP4,328,479$35.36M0.2%-39.4%6.310%
2/14/2024 Commodore Capital LP3,800,000$21.47M1.9%N/A7.711%
2/14/2024 Wasatch Advisors LP7,138,949$40.34M0.2%+14.3%14.487%
2/14/2024 Bellevue Group AG62,000$350K0.0%N/A0.126%
2/14/2024 Lighthouse Investment Partners LLC21,981$124K0.0%N/A0.045%
2/13/2024 Tower Research Capital LLC TRC16,322$92K0.0%+33.1%0.033%
2/2/2024 Headlands Technologies LLC6,880$39K0.0%N/A0.014%
1/16/2024Raymond James & Associates100,984$571K0.0%+10.5%0.205%
1/12/2024FNY Investment Advisers LLC8,800$49K0.1%N/A0.018%
12/19/2023 Public Employees Retirement System of Ohio71,163$132K0.0%-65.7%0.144%
12/6/2023 Citigroup Inc.57,894$108K0.0%+214.6%0.117%
11/14/2023 Lynx1 Capital Management LP1,019,230$1.90M1.3%N/A2.068%
11/13/2023 Connor Clark & Lunn Investment Management Ltd.164,722$306K0.0%-5.5%0.334%
11/13/2023 Algert Global LLC51,760$96K0.0%-12.4%0.105%
11/13/2023 Acadian Asset Management LLC28,014$51K0.0%-78.1%0.057%
11/7/2023 Barclays PLC43,614$81K0.0%+30.7%0.089%
11/2/2023 M&T Bank Corp140,020$260K0.0%N/A0.285%
10/24/2023Raymond James & Associates91,380$170K0.0%+8.5%0.186%
10/20/2023 Harbor Capital Advisors Inc.70,703$132K0.0%+20.6%0.144%
9/21/2023 Barclays PLC33,368$92K0.0%-29.5%0.068%
8/14/2023 ArrowMark Colorado Holdings LLC309,755$852K0.0%-95.1%0.630%
8/14/2023 TCG Crossover Management LLC1,276,574$3.51M0.6%+2.1%2.595%
8/14/2023 Prelude Capital Management LLC34,000$94K0.0%N/A0.069%
8/14/2023 Graham Capital Management L.P.32,974$91K0.0%N/A0.067%
8/11/2023 Pale Fire Capital SE19,200$53K0.0%N/A0.039%
8/11/2023 B. Metzler seel. Sohn & Co. AG66,276$182K0.0%+265.8%0.135%
8/8/2023 Wasatch Advisors LP7,199,491$19.80M0.1%+26.0%14.675%
8/7/2023 Acadian Asset Management LLC128,060$351K0.0%N/A0.261%
7/25/2023Raymond James & Associates84,234$232K0.0%+33.5%0.172%
Nvidia’s Bold Move: Tackling Tech’s $1 Trillion Crisis (Ad)

Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …

Find out details on these three critical Nvidia partners immediately.
7/11/2023 Harbor Capital Advisors Inc.58,647$161K0.0%+10.1%0.120%
7/10/2023 SG Americas Securities LLC12,810$35K0.0%-54.3%0.026%
5/12/2023 Martingale Asset Management L P39,420$124K0.0%+20.6%0.080%
5/11/2023 M&T Bank Corp72,000$226K0.0%+17.5%0.147%
5/11/2023 Cornercap Investment Counsel Inc.48,047$151K0.0%+82.8%0.098%
5/10/2023 B. Metzler seel. Sohn & Co. AG18,120$57K0.0%N/A0.037%
5/10/2023 Connor Clark & Lunn Investment Management Ltd.113,893$358K0.0%+687.8%0.232%
5/9/2023 Y Intercept Hong Kong Ltd31,362$98K0.0%N/A0.064%
4/28/2023 SG Americas Securities LLC28,013$88K0.0%-32.6%0.057%
4/26/2023 Harbor Capital Advisors Inc.53,278$167K0.0%+113.7%0.109%
(Data available from 1/1/2016 forward)

CCCC Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of CCCC shares?

During the previous two years, 72 institutional investors and hedge funds held shares of C4 Therapeutics. The most heavily invested institutionals were Wasatch Advisors LP ($32.36M), Lynx1 Capital Management LP ($31.79M), Vanguard Group Inc. ($23.86M), Commodore Capital LP ($21.47M), Price T Rowe Associates Inc. MD ($17.28M), State Street Corp ($16.00M), and Bain Capital Life Sciences Investors LLC ($9.33M).Learn more on CCCC's institutional investors.

What percentage of C4 Therapeutics stock is owned by institutional investors?

78.81% of C4 Therapeutics stock is owned by institutional investors. Learn more on CCCC's institutional investor holdings.

Which institutional investors have been buying C4 Therapeutics stock?

Of the 56 institutional investors that purchased C4 Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Lynx1 Capital Management LP ($4.77M), Commodore Capital LP ($3.80M), Wasatch Advisors LP ($3.21M), Point72 Asset Management L.P. ($923.27K), Vanguard Group Inc. ($920.63K), Acadian Asset Management LLC ($219.50K), and Hennion & Walsh Asset Management Inc. ($192.36K).

How much institutional buying is happening at C4 Therapeutics?

Institutional investors have bought a total of 16,313,375 shares in the last 24 months. This purchase volume represents approximately $81.94M in transactions.

Which C4 Therapeutics major shareholders have been selling company stock?

Of the 27 institutional investors that sold C4 Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: ArrowMark Colorado Holdings LLC ($6.07M), Wasatch Advisors LP ($2.81M), Point72 Asset Management L.P. ($627.89K), Bain Capital Life Sciences Investors LLC ($500K), Price T Rowe Associates Inc. MD ($443.00K), Cubist Systematic Strategies LLC ($407.81K), and Driehaus Capital Management LLC ($260.75K).

How much institutional selling is happening at C4 Therapeutics?

Institutional investors have sold a total of 12,331,750 shares in the last 24 months. This volume of shares sold represents approximately $59.35M in transactions.



This page (NASDAQ:CCCC) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners